Navigation Links
FlowTACS Flow Cytometry Apoptosis Detection Kit from R&D Systems

ProductsFlowTACS Flow Cytometry Apoptosis Detection Kit from R&D Systems
Company R&D Systems
Item FlowTACS Flow Cytometry Apoptosis Detection Kit
Price $345.00
Description The FlowTACS Apoptosis Detection Kit is designed specifically for in situdetection of apoptotic
Info R&D SystemsR&D Systems
R&D Systems, Inc.
614 McKinley Place N.E.
Minneapolis, MN 55413
Customer Service: 1 (800) 343-7475
1 (612) 379-2956

Fax Number: 1 (612) 656-4400
Web Site: http://www.rndsystems.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. CompenFlow Flow Cytometry Compensation Kit 6 m from Molecular Probes (Invitrogen)
2. Apo-BRDU Flow Cytometry Detection Kit from CHEMICON
3. Flow Cytometry Kit for Apoptosis from Sigma-Aldrich
4. Cytomics FC 500 Series Flow Cytometry Systems from Beckman Coulter
5. Cytomics FC 500 Series Flow Cytometry Systems from Beckman Coulter
6. Cytomics FC 500 Series Flow Cytometry Systems from Beckman Coulter
7. H2A.X Phosphorylation Assay Kit (Flow Cytometry) from Upstate
8. Human Regulatory T cell (Foxp3 / CD4 / CD25) Flow Cytometry staining Kit from eBioscience
9. Apo-Direct Apoptosis Detection Kit from eBioscience
10. ApopTag Fluorescein Direct In Situ Apoptosis Detection Kit from CHEMICON
11. ApopTag Fluorescein In Situ Apoptosis Detection Kit from CHEMICON
Mouse monoclonal [CIG 3A11/5] to Cig2 (rating: *****) ( Abpromise for all tested applications)....
Phospho-CD18 (Ser756/Thr758/759) Antibody Shipping Temperature: HOT Storage Temperature: -20C...
Goat polyclonal to SART1 ( Abpromise for all tested applications). Antigen: Synthetic peptide: GSSKKHRGEKEAA, corresponding to N terminal amino acids 2-14 of Human SART1. Entrez Gene ID: 909...
Phospho-Cyclin D1 (Thr286) Antibody...
Biology Products:
(Date:4/20/2015)... PASADENA, Calif. , April 20, 2015 ... San Gabriel Valley to implant a new miniaturized, wireless ... HF System is the first and only FDA-approved heart ... reduce hospital admissions when used by physicians to manage ... a sensor that is implanted in the pulmonary artery ...
(Date:4/20/2015)... The announcement comes as demand for fire ... Ireland,s foremost records management company, has ... an impressive track record of clients within the first 12 ... management sector in Dubai . As a ... employ a further eight staff members at its Irish headquarters. ...
(Date:4/17/2015)... Increasing adoption in ... to drive biometric systems market in ... According to a recently released TechSci Research ... biometric systems market in Saudi Arabia ... CAGR of over 22% through 2020. The market ...
Breaking Biology News(10 mins):Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 2Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 3Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 2Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 3Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 2Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 3
... WASHINGTON -- The most effective way to prevent the deliberate ... housed in laboratories across the U.S. considered to potentially pose ... culture of trust and responsibility in the laboratory, says a ... the laboratory environment will be critical for identifying and reducing ...
... that the pace of biodiversity loss is worsening in ... Cape Town October 13-16 for the DIVERSITAS Open Science ... of biodiversity have continued to accelerate. Since 1992, the ... than the size of California has been converted mostly ...
... to the AZTI-Tecnalia researchers, the first estimations of the geographical ... undertaken migrations between the Azores and Portugal during the winter, ... and also that it had dived, during the winter, to ... was tagged 26 of August 2008 in the Gulf of ...
Cached Biology News:Securing biological select agents and toxins will require developing a culture of trust 2Securing biological select agents and toxins will require developing a culture of trust 3Juvenile bluefin tunas can dive to depths of more than 1000 meters 2
(Date:4/21/2015)... (PRWEB) April 21, 2015 Staying true ... to craft a digital product that makes the world ... with Global Biological Standards Institute (GBSI) to redesign their ... clean, and most importantly, strategy-based. , "Biomedical research is ... - much less to promote it in a narrative ...
(Date:4/21/2015)... LA JOLLA, Calif. , April 21, 2015 ... (JCVI), a not-for-profit genomic research organization, published a ... manipulate a type of microalgae called diatoms. The ... , Ph.D. and senior author Philip Weyman ... methods will enable better understanding of diatom genetics ...
(Date:4/21/2015)... 21, 2015 AbilTo, Inc., the nation,s leading ... submission has been accepted as a presentation to be ... taking place on June 5-6, 2015 in Boston, ... American Diabetes Association, the cost of diabetes to the ... a result of increased inpatient, outpatient, and pharmacy costs, ...
(Date:4/21/2015)... 21, 2015 Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK ... Phase 1 study of MM-141, a bispecific antibody targeting ... oral session by Dr. Mansoor Saleh , MD ... Meeting in Philadelphia, PA.  The ... a monotherapy and in combination with everolimus or with ...
Breaking Biology Technology:Visceral Tells GBSI’s Story Within 30 Seconds of Attention 2Visceral Tells GBSI’s Story Within 30 Seconds of Attention 3Scientists at the J. Craig Venter Institute Publish Paper Outlining Efficient Synthetic Biology Methods to Genetically Engineer Microalgae 2Scientists at the J. Craig Venter Institute Publish Paper Outlining Efficient Synthetic Biology Methods to Genetically Engineer Microalgae 3AbilTo To Present at the 2015 American Diabetes Association Annual Meeting on Remote Delivery of Behavioral Change Therapy 2AbilTo To Present at the 2015 American Diabetes Association Annual Meeting on Remote Delivery of Behavioral Change Therapy 3First-in-Human Phase 1 Trial of MM-141 Demonstrates Activity in Biomarker Positive Patients 2First-in-Human Phase 1 Trial of MM-141 Demonstrates Activity in Biomarker Positive Patients 3First-in-Human Phase 1 Trial of MM-141 Demonstrates Activity in Biomarker Positive Patients 4First-in-Human Phase 1 Trial of MM-141 Demonstrates Activity in Biomarker Positive Patients 5